Canada’s Drug Agency (CDA-AMC)
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and clinical interventions — and includes new work streams such as:
- improving the appropriate prescribing and use of medications
- increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data
- reducing drug system duplication and lack of coordination
CADTH adopted the new name Canada’s Drug Agency (CDA-AMC) as of May 1, 2024. An official launch will occur later this year.
CCRA Responds to the Engagement Request on Federal Research Support Restructuring
On behalf of the Alliance, a group of CCRA members formulated a response to a statement ... Read More »
On behalf of the Alliance, a group of CCRA members formulated a response to a statement ... Read More »
New Funding Opportunity from CIHR IHSPR
The Policy Research for Health System Transformation program will support 24 one-year grants ($150,000 each) that generate evidence to inform macro-level policies and support high-performing health care and public health systems in Canada. The applic... Read More »
The Policy Research for Health System Transformation program will support 24 one-year grants ($150,000 each) that generate evidence to inform macro-level policies and support high-performing health care and public health systems in Canada. The applic... Read More »